MedImmune

company

About

MedImmune develops medicines for unmet medical needs worldwide.

  • 5001 - 10000

Highlights

Details

Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 1987
Number Of Employee
5001 - 10000
Operating Status
Active

MedImmune develops medicines for unmet medical needs worldwide.

As the global biologics research and development arm of AstraZeneca, MedImmune is pioneering innovative research and exploring novel pathways across key therapeutic including respiratory, inflammation, and autoimmunity; cardiovascular and metabolic disease; oncology; neuroscience; and infection and vaccines. Since its founding in 1988, MedImmune has remained committed to scientific innovation and medical progress, continually looking beyond standard expectations and pushing the boundaries of what is possible.

Investments

Number of Investments
Number of Lead Investments
1
0
MedImmune has made 1 investments. Their most recent investment was on Apr 25, 2018, when Corvidia raised $60M.
Date Company Name
Round Money Raised Industry Lead Investor
Apr 25, 2018 Corvidia
Series B $60M Biotechnology